Messinger Michael purchased $2K of ICU

Messinger Michael (Chief Financial Officer) purchased 750 shares of SeaStar Medical Holding Corp (ICU) at $3.27 on 2026-08-18.

Original reporting
SEC EDGAR · Messinger Michael
Published Aug 19, 2026, 8:21 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 19, 2026, 8:25 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ICU
Bullish
low confidence
Mentioned
$ICU
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ICUBullishLow
01

Why it matters

Traders may note the CFO’s open-market buy, but the disclosed dollar value is too small to materially alter valuation expectations.

02

Market read

A small CFO open-market buy is a mild sentiment datapoint with limited trading impact.

03

What to watch

The filing does not indicate a 10b5-1 plan and does not provide context on prior buying patterns, option exercises, or whether the CFO’s compensation structure drives periodic purchases.

Relevance 4/10Novelty 2/10Timing: Filed 2026-08-19 after-hours, based on 2026-08-18 purchase.

Background

The article is an SEC Form 4 insider transaction disclosure for SeaStar Medical Holding Corp (ICU).

Company-level read

Ticker impact

$ICUBullishLow confidence
Context

CFO Michael Messinger filed a Form 4 open-market purchase of 750 shares at $3.2700 on 2026-08-18, totaling $2,452.50.

Expected impact

Low likelihood of a near-term price move; any effect is likely sentiment-driven and limited.

Evidence & confidence

The transaction size is small ($2.5k) and is not a 10b5-1 plan; insider buys can be informative, but this disclosure alone typically lacks the scale to change fundamentals or guidance.

Market effects

No clear sector read-through from a single small insider buy.

None.

None.

Counterpoint

Insider purchases can be routine liquidity or diversification rather than a strong forward-looking signal, especially at small dollar amounts.

Key entities

  • SeaStar Medical Holding Corp

    Subject of the Form 4 insider transaction disclosure.

  • Michael Messinger

    Chief Financial Officer who purchased 750 shares open-market.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ICUHigh

SeaStar Medical Reports Third Quarter 2026 Financial Results and Provides Business Updates

SeaStar Medical Holding Corp (ICU) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 SeaStar Medical Reports Third Quarter 2026 Financial Results and Provides Business Updates Continued adoption of the QUELIMMUNE ® therapy yielded 247% increase in net revenue compared to the third quarter of 2025 Achieved nearly 75% enrollment in the NEUTRALIZE-AKI p